1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)
THE UTERINE AND CARDIOVASCULAR EFFECTS OF ORAL FENOTEROL HYDROBROMIDE
Article first published online: 23 AUG 2005
DOI: 10.1111/j.1471-0528.1977.tb12482.x
Issue
1471-0528/asset/cover.gif?v=1&s=b4e1d96c46e18c61210d584b63c13ee375cf562b "BJOG: An International Journal of Obstetrics & Gynaecology")
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 84, Issue 10, pages 737–739, October 1977
Additional Information
How to Cite
Lipshitz, J. (1977), THE UTERINE AND CARDIOVASCULAR EFFECTS OF ORAL FENOTEROL HYDROBROMIDE. BJOG: An International Journal of Obstetrics & Gynaecology, 84: 737–739. doi: 10.1111/j.1471-0528.1977.tb12482.x
Publication History
- Issue published online: 23 AUG 2005
- Article first published online: 23 AUG 2005
- Abstract
- References
- Cited By
Summary
Fenoterol hydrobromide was administered as a 5 mg tablet to 10 patients in oxytocin-induced labour and the effects on uterine activity and on the cardiovascular system of mother and baby were evaluated. The drug took effect within 30 minutes in 8 of the 10 patients and it reduced uterine activity to less than 30 per cent of the original. Fenoterol caused a moderate maternal tachycardia, raised systolic and decreased the diastolic blood pressures.